Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,527,575
  • Shares Outstanding, K 101,500
  • Annual Sales, $ 36,570 K
  • Annual Income, $ -54,570 K
  • 36-Month Beta 2.92
  • Price/Sales 41.77
  • Price/Cash Flow N/A
  • Price/Book 7.19

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.00 +16.15%
on 06/28/18
18.19 -17.01%
on 06/21/18
-2.95 (-16.34%)
since 06/20/18
3-Month
13.00 +16.15%
on 06/28/18
19.25 -21.56%
on 04/23/18
-3.95 (-20.73%)
since 04/20/18
52-Week
8.00 +88.75%
on 08/01/17
27.50 -45.09%
on 02/22/18
+5.55 (+58.12%)
since 07/20/17

Most Recent Stories

More News
Sangamo Therapeutics Announces Technology Leadership Changes

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced that Michael Holmes, Ph.D., Senior Vice President and Chief Technology Officer, will resign from the Company effective July 20th to pursue an opportunity...

SGMO : 15.10 (+0.33%)
SmarTrend Watching for Potential Rebound in Shares of Sangamo Therapeu After 3.43% Loss

Sangamo Therapeu (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $14.75 to a high of $15.55. Yesterday, the shares fell 3.4%, which took the trading range below the 3-day low of...

SGMO : 15.10 (+0.33%)
Stem Cell Companies Innovating for the Future

FN Media Group Presents Microcapspeculators.com News Commentary

SGMO : 15.10 (+0.33%)
BRTX : 1.6900 (+5.63%)
VCEL : 10.60 (+1.92%)
FATE : 10.82 (-2.35%)
ATHX : 2.07 (unch)
Rise of Chronic Diseases Leads to Growing Investment in Stem Cell Research

According to a report published by Transparency Market Research, the global stem cell market is expected to reach US 270.5 Billion by 2025, while increasing at a compound annual growth rate of 13.8% during...

SGMO : 15.10 (+0.33%)
ISCO : 1.5400 (-2.53%)
CBMG : 21.40 (+7.00%)
VCEL : 10.60 (+1.92%)
ATHX : 2.07 (unch)
Sangamo Therapeu Down 29.0% Since SmarTrend Downtrend Call (SGMO)

SmarTrend identified a Downtrend for Sangamo Therapeu (NASDAQ:SGMO) on March 23rd, 2018 at $22.45. In approximately 4 months, Sangamo Therapeu has returned 28.95% as of today's recent price of $15.95....

SGMO : 15.10 (+0.33%)
Complimentary Technical Snapshots on Verastem and Three More Biotech Stocks

Stock Research Monitor: RXII, SAGE, and SGMO

SGMO : 15.10 (+0.33%)
Sangamo Therapeu Shares Down 34.4% Since SmarTrend's Sell Call (SGMO)

SmarTrend identified a Downtrend for Sangamo Therapeu (NASDAQ:SGMO) on March 23rd, 2018 at $22.45. In approximately 3 months, Sangamo Therapeu has returned 34.41% as of today's recent price of $14.73....

SGMO : 15.10 (+0.33%)
Sangamo Therapeutics Appoints Karen Smith to its Board of Directors

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the appointment of Dr. Karen Smith, an accomplished drug development executive, to the Company's Board of Directors.

SGMO : 15.10 (+0.33%)
After Yesterday's Decline of 7.83%, Sangamo Therapeu Offers Investors Better Value

Sangamo Therapeu (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $14.30 to a high of $15.80. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low of...

SGMO : 15.10 (+0.33%)
Sangamo Therapeu Has Returned 27.5% Since SmarTrend Recommendation (SGMO)

SmarTrend identified a Downtrend for Sangamo Therapeu (NASDAQ:SGMO) on March 23rd, 2018 at $22.45. In approximately 3 months, Sangamo Therapeu has returned 27.51% as of today's recent price of $16.28....

SGMO : 15.10 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade SGMO with:

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

2nd Resistance Point 15.50
1st Resistance Point 15.30
Last Price 15.10
1st Support Level 14.85
2nd Support Level 14.60

See More

52-Week High 27.50
Fibonacci 61.8% 20.05
Fibonacci 50% 17.75
Fibonacci 38.2% 15.45
Last Price 15.10
52-Week Low 8.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar